BMRN vs SAFT · P/E 40, rev $2.85B vs P/E 17, rev $1.26B
Biomarin Pharmaceutical Inc (BMRN) versus Safety Insurance Group Inc (SAFT) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Safety Insurance Group Inc (SAFT) is a insurance - property & casualty company listed on NASDAQ.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported SAFT revenue for 2025-12-31 was $1.26B. Net income was $99.3M. Revenue was up 12.8% from 2024-12-31 to 2025-12-31. SAFT currently screens at market cap $1.04B and trailing P/E 16.7.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. SAFT currently screens at market cap $1.04B and trailing P/E 16.7.
Not investment advice. Open the BMRN and SAFT stock pages for the full models.
Not investment advice.